Gandhar Oil Refinery (India) Ltd
NSE: GANDHAR BSE: 544029Healthcare
Incorporated in 1992, Gandhar Oil Limited is a prominent manufacturer of white oils that caters to the consumer and healthcare end industries.[1]
₹155
52W: ₹115 — ₹184
PE 14.4 · Book ₹125 · +24% vs bookMarket Cap₹1,517 Cr
Stock P/E14.4Price to Earnings
ROCE11.4%Return on Capital
ROE6.59%Return on Equity
Div. Yield0.48%Face Value ₹2
Strengths
- +Company is almost debt free.
Weaknesses
- −The company has delivered a poor sales growth of 5.96% over past five years.
- −Company has a low return on equity of 13.6% over last 3 years.
- −Dividend payout has been low at 4.33% of profits over last 3 years
Shareholding Pattern
Promoters66.47%
FIIs0.14%
DIIs0.09%
Public33.3%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 64.63% | 64.63% | 64.63% | 65.01%▲0.4 | 65.01% | 65.01% | 66.18%▲1.2 | 66.47%▲0.3 |
| FIIs | 0.18% | 0.02%▼0.2 | 0.62%▲0.6 | 0.18%▼0.4 | 0.24%▲0.1 | 0.17%▼0.1 | 0.34%▲0.2 | 0.14%▼0.2 |
| DIIs | 2.65% | 1.84%▼0.8 | 1.7%▼0.1 | 1.79%▲0.1 | 1.97%▲0.2 | 2.05%▲0.1 | 0.43%▼1.6 | 0.09%▼0.3 |
| Public | 32.56% | 33.52%▲1.0 | 33.05%▼0.5 | 33.03%▼0.0 | 32.8%▼0.2 | 32.77%▼0.0 | 33.05%▲0.3 | 33.3%▲0.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 690 | 737 | 717 | 790 | 761 | 857 | 752 | 745 | 807 | 923 |
| Expenses | 637 | 666 | 701 | 739 | 727 | 823 | 725 | 705 | 755 | 873 |
| Operating Profit | 53 | 71 | 17 | 51 | 35 | 34 | 26 | 41 | 52 | 49 |
| OPM % | 8% | 10% | 2% | 6% | 5% | 4% | 4% | 5% | 6% | 5% |
| Net Profit | 30 | 44 | 6 | 29 | 18 | 18 | 11 | 26 | 32 | 36 |
| EPS ₹ | 3.81 | 4.46 | 0.62 | 2.96 | 1.87 | 1.79 | 1.08 | 2.68 | 3.29 | 3.66 |
AI Insights
Revenue Trend
TTM revenue at ₹3,227Cr, up 2.1% YoY. OPM at 5%.
Debt Position
Borrowings at ₹89Cr. Debt-to-equity ratio: 0.07x. Healthy balance sheet.
Capex Cycle
CWIP at ₹31Cr (10% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.09% (-10.63pp change). FIIs: 0.14% (-3.73pp change). Promoters hold 66.47%.
Margin & Efficiency
ROCE improving from 0% (Mar 2018) to 11% (Mar 2025). Working capital days: 88.
Valuation
PE 14.4x with 11.4% ROCE. Price is 24% above book value of ₹125. Dividend yield: 0.48%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Resignation of Director 12 May - Mrs. Deena Mehta resigned as independent director effective May 12, 2026, citing pre-occupation.
- Announcement under Regulation 30 (LODR)-Change in Management 12 May - Mr. Sanjay Bharadwaj resigned as Senior Vice President, Manufacturing, effective 11 May 2026.
- Announcement under Regulation 30 (LODR)-Change in Management 11 May - Senior Vice President Manufacturing Sanjay Bharadwaj resigned from Silvassa Plant effective May 5, 2026.
- Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 For An Order Received From The Office Of The Commissioner Of Customs (Appeals), Mumbai -I. 7 May - Customs appeal order dated 30 Apr 2026 sanctions Rs 22.92 crore refund for 2018-19 and 2019-20.
- Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Update On Purchase Of Land 6 May - Purchased 18,353 sq. mtr. land near Silvassa factory for Rs. 22.78 crore.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Rating update 6 May from smera